O'Hare Ann M, Kurella Tamura Manjula, Lavallee Danielle C, Vig Elizabeth K, Taylor Janelle S, Hall Yoshio N, Katz Ronit, Curtis J Randall, Engelberg Ruth A
Department of Medicine, University of Washington, Seattle.
Kidney Research Institute, University of Washington, Seattle.
JAMA Intern Med. 2019 Oct 1;179(10):1325-1333. doi: 10.1001/jamainternmed.2019.2879.
Prognostic understanding can shape patients' treatment goals and preferences. Patients undergoing dialysis in the United States have limited life expectancy and may receive end-of-life care directed at life extension. Little is known about their prognostic expectations.
To understand the prognostic expectations of patients undergoing dialysis and how these relate to care planning, goals, and preferences.
DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional survey study of 996 eligible patients treated with regular dialysis at 31 nonprofit dialysis facilities in 2 metropolitan areas (Seattle, Washington, and Nashville, Tennessee) between April 2015 and October 2018. After a pilot phase, 1434 eligible patients were invited to participate (response rate, 69.5%). To provide a context for interpreting survey participants' prognostic estimates, United States Renal Data System standard analysis files were used to construct a comparison cohort of 307 602 patients undergoing in-center hemodialysis on January 1, 2006, and followed for death through July 31, 2017. Final analyses for this study were conducted between November 2018 and March 2019.
Responses to the question "How long would you guess people your age with similar health conditions usually live?" (<5 years, 5-10 years, >10 years, or not sure).
Self-reported (1) documentation of a surrogate decision-maker, (2) documentation of treatment preferences, (3) values around life prolongation, (4) preferences for receipt of cardiopulmonary resuscitation and mechanical ventilation, and (5) desired place of death.
Of the 996 survey respondents, the mean (SD) age was 62.7 (13.9) years, and 438 (44.0%) were women. Overall, 112 (11.2%) survey respondents selected a prognosis of fewer than 5 years, 150 (15.1%) respondents selected 5 to 10 years, 330 (33.1%) respondents selected more than 10 years, and 404 (40.6%) were not sure. By comparison, 185 427 (60.3%) prevalent US in-center patients undergoing hemodialysis died within 5 years, 58 437 (19.0%) died within 5 to 10 years, and 63 738 (20.7%) lived more than 10 years. In analyses adjusted for participant characteristics, survey respondents with a prognostic expectation of more than 10 years (vs <5 years) were less likely to report documentation of a surrogate decision-maker (adjusted odds ratio [aOR], 0.6; 95% CI, 0.4-0.9) and treatment preferences (aOR, 0.4; 95% CI, 0.2-0.6) and to value comfort over life extension (aOR, 0.1; 95% CI, 0.04-0.3), and were more likely to want cardiopulmonary resuscitation (aOR, 5.3; 95% CI, 3.2-8.7) and mechanical ventilation (aOR, 2.2; 95% CI, 1.2-3.7). The respondents who reported that they were not sure about prognosis had similar associations.
Uncertain and overly optimistic prognostic expectations may limit the benefit of advance care planning and contribute to high-intensity end-of-life care in patients undergoing dialysis.
对预后的理解会影响患者的治疗目标和偏好。在美国,接受透析治疗的患者预期寿命有限,可能会接受旨在延长生命的临终护理。对于他们的预后期望,人们知之甚少。
了解接受透析治疗患者的预后期望,以及这些期望与护理计划、目标和偏好之间的关系。
设计、地点和参与者:2015年4月至2018年10月期间,对华盛顿州西雅图市和田纳西州纳什维尔市两个大都市地区31家非营利性透析机构的996名接受定期透析治疗的合格患者进行横断面调查研究。在试点阶段之后,邀请了1434名合格患者参与(回复率为69.5%)。为了解释调查参与者的预后估计情况,使用美国肾脏数据系统标准分析文件构建了一个比较队列,该队列由2006年1月1日接受中心血液透析且截至2017年7月31日随访死亡情况的307602名患者组成。本研究的最终分析于2018年11月至2019年3月进行。
对“你猜与你年龄相仿、健康状况相似的人通常能活多久?”这一问题的回答(<5年、5 - 10年、>10年或不确定)。
自我报告的(1)指定替代决策者的记录,(2)治疗偏好的记录,(3)围绕延长生命的价值观,(4)对接受心肺复苏和机械通气的偏好,以及(5)期望的死亡地点。
在996名调查受访者中,平均(标准差)年龄为62.7(13.9)岁,438名(44.0%)为女性。总体而言,112名(11.2%)调查受访者选择的预后少于5年,150名(15.1%)受访者选择5至10年,330名(33.1%)受访者选择超过10年,404名(40.6%)不确定。相比之下,美国接受中心血液透析的现患患者中,185427名(60.3%)在5年内死亡,58437名(19.0%)在5至10年内死亡,63738名(20.7%)存活超过10年。在针对参与者特征进行调整的分析中,预后期望超过10年(与<5年相比)的调查受访者报告有替代决策者记录(调整后的优势比[aOR],0.6;95%置信区间[CI],0.4 - 0.9)和治疗偏好(aOR,0.4;95% CI,0.2 - 0.6)的可能性较小,并更看重舒适而非延长生命(aOR,0.1;95% CI,0.04 - 0.3),且更有可能希望进行心肺复苏(aOR,5.3;95% CI,3.2 - 8.7)和机械通气(aOR,2.2;95% CI,1.2 - 3.7)。报告对预后不确定的受访者也有类似的关联。
不确定和过度乐观的预后期望可能会限制预先护理计划的益处,并导致透析患者接受高强度的临终护理。